Regulatory Strategy & Product Approvals

MedOrdyn supports medical device and Software as a Medical Device (SaMD) manufacturers in navigating global regulatory pathways through structured, evidence-driven strategies tailored to each product, technology, and target market. Regulatory success requires more than submission preparation. It begins with a clear understanding of device classification, intended use, regulatory pathways, and jurisdiction-specific expectations. MedOrdyn focuses on building this foundation early in the product lifecycle to ensure efficient approvals and minimize regulatory risk.

Our approach integrates regulatory strategy with product development, risk management, and quality system alignment, ensuring that documentation, clinical evidence, and technical requirements are consistent with global regulatory frameworks such as US FDA, EU MDR/IVDR, and other international standards. By establishing a structured regulatory roadmap, we help organizations avoid delays, reduce rework, and achieve predictable outcomes across multiple markets.

US FDA 510(k) Clearance

MedOrdyn provides end-to-end support for FDA 510(k) submissions, including pathway determination, predicate device identification, and regulatory strategy development. We assist in preparing structured submission content, including device description, substantial equivalence rationale, performance data, and risk documentation. Our support also includes coordination with the FDA during review cycles, addressing queries, and ensuring that submissions are aligned with current FDA expectations and guidance documents.

EU MDR CE Marking

We support manufacturers in achieving CE Marking under EU MDR by guiding conformity assessment strategy, classification, and selection of the appropriate regulatory pathway. MedOrdyn assists in preparing and reviewing Technical Documentation, including General Safety and Performance Requirements (GSPR), clinical evaluation, risk management integration, and post-market requirements. We also support interactions with Notified Bodies to ensure a smooth and structured certification process.

SaMD Regulatory Support

For Software as a Medical Device, MedOrdyn provides regulatory strategy and documentation support aligned with global digital health requirements. This includes classification, software lifecycle considerations, cybersecurity aspects, clinical evaluation, and alignment with standards such as IEC 62304 and ISO 14971. We ensure that software-specific regulatory expectations are addressed systematically within both submissions and quality systems.

MDSAP Compliance Support

MedOrdyn assists organizations in aligning their Quality Management Systems with the Medical Device Single Audit Program (MDSAP). Our support includes gap assessment against MDSAP requirements, process alignment, and audit readiness preparation. We help ensure that QMS processes meet the expectations of participating regulatory authorities, enabling efficient multi-country compliance through a single audit framework.

Submission Dossier Preparation

We provide structured development, review, and optimization of regulatory submission dossiers tailored to specific market requirements. This includes ensuring consistency across technical documentation, risk management files, clinical data, and labeling. Our focus is on creating clear, defensible, and regulator-ready submissions that support efficient review and approval.

Global Market Entry Strategy

MedOrdyn supports organizations in planning and executing global market entry through strategic sequencing of regulatory approvals. We provide guidance on selecting target markets, aligning documentation requirements, and optimizing submission timelines. By considering regulatory dependencies, resource planning, and lifecycle implications, we help manufacturers achieve efficient and scalable global expansion.